Lessons learned from COVID-19
in pharmacovigilance practice

Webinar:

19th of August 2020, 6pm (Egypt) / 7pm (KSA) / 8pm UAE

In Collaboration With:

ISOP

The COVID-19 Crisis has challenged the world including the Pharmacovigilance systems. One of the most important lessons learned from this crisis is how to keep the pharmacovigilance process uninterrupted specially the critical processes including:

  • Monitoring and benefit-risk
  • Risk management systems
  • Collection & processing individual case safety reports (ICSRs)
  • Signal management
  • Scheduling, preparation of periodic safety update reports
  • Meeting commitments and responding to requests from national medicines authorities
  • Interaction between the pharmacovigilance and product quality defect systems
  • Communication about safety concerns between marketing authorization holders and national medicines authorities,
  • Safety communicating
  • Keeping product information up-to-date with the current scientific knowledge
  • Implementation of safety variations to marketing authorizations

This webinar will highlight practical examples on business continuity of such process

 

OUR EXPERTS:

Dr. Hadir Rostom

Dr. Hadir Rostom

President
ISoP Egypt Chapter

Dr. Rouba Eid

Dr. Rouba Eid

Pharm-D USA FDA fellow, Regional Pharmacovigilance Director
Middle East/Africa, Bausch Health Companies

Dr. Sandra Rambahal

Dr. Sandra Rambahal

PV Regional Head Eastern Europe, Middle East & Africa
Bayer AG (Berlin)